Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sickle cell intrahepatic cholestasis with cholelithiasis.

Karina Irizarry1, Hans Christof Rossbach, Joseph R A Ignacio

  • 1Department of Pediatrics, University of South Florida College of Medicine, Tampa, Florida, USA. mjwilsey@tampabay.rr.com

Pediatric Hematology and Oncology
|May 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Infant Colic Symptoms and Amino Acid Formula: Insights from a Prospective Cohort Study.

Nutrients·2025
Same author

Pancreatic Cystic Lesions in Children: A Comprehensive Scoping Review.

Pancreas·2025
Same author

Real-Time Data Collection Utilizing Mobile Technology in Clinical Research: A Secondary Analysis of a Prospective Cohort.

Cureus·2024
Same author

Management Strategies and Outcomes of Distal Congenital Esophageal Strictures in the Setting of Long-gap Esophageal Atresia.

Journal of pediatric surgery·2024
Same author

Managing cow's milk protein allergy during the 2022 formula shortage: decision-making among pediatric healthcare providers.

Frontiers in allergy·2024
Same author

Natural airway as an alternative to intubation for pediatric endoscopic esophageal foreign body removal: A retrospective cohort study of 326 patients.

Paediatric anaesthesia·2024
Same journal

Neuromuscular Changes During the Six-Minute Walk Test in Pediatric Sickle Cell Disease.

Pediatric hematology and oncology·2026
Same journal

Early discharge for low-risk pediatric febrile neutropenia: safe only in selected centers.

Pediatric hematology and oncology·2026
Same journal

Clinical and microbiological characteristics of viridans group streptococcal bacteremia in pediatric and adolescent patients with cancer.

Pediatric hematology and oncology·2026
Same journal

Parental and Patients' Awareness, Knowledge, and Willingness for Human Papillomavirus Vaccination Among Survivors of Childhood Hematologic Malignancies.

Pediatric hematology and oncology·2026
Same journal

How we Investigate Bone Marrow Failure Syndromes in Pediatric Patients.

Pediatric hematology and oncology·2026
Same journal

Prepubertal Initiation of Imatinib is Associated with Reduced Final Height in Children with Chronic Myeloid Leukemia.

Pediatric hematology and oncology·2026
See all related articles

Sickle cell intrahepatic cholestasis (SCIC) is a rare but serious complication in sickle cell disease patients. Early diagnosis and exchange transfusion are crucial for managing this condition and preventing severe outcomes.

Area of Science:

  • Hepatology
  • Hematology
  • Internal Medicine

Background:

  • Sickle cell intrahepatic cholestasis (SCIC) is a rare, severe complication of sickle cell disease.
  • It presents with RUQ pain, hepatomegaly, elevated transaminases, coagulopathy, and hyperbilirubinemia.
  • Distinguishing SCIC from other hepatobiliary conditions in sickle cell patients is diagnostically challenging.

Observation:

  • The authors describe two cases of SCIC in patients with sickle cell disease and cholelithiasis.
  • One patient also presented with choledocholithiasis, complicating the clinical picture.
  • These cases highlight the diagnostic difficulties and potential co-existing biliary pathology.

Findings:

  • SCIC requires prompt recognition to prevent life-threatening complications.

Related Experiment Videos

  • Current treatment options for SCIC are limited, with exchange transfusion being the primary intervention.
  • The presence of gallstones and common bile duct stones can further complicate SCIC management.

    • Implications:

    • Enhanced awareness of SCIC is needed among clinicians managing sickle cell patients.
    • Further research into diagnostic markers and novel therapeutic strategies for SCIC is warranted.
    • Understanding the interplay between sickle cell disease, cholelithiasis, and cholestasis is essential for improved patient outcomes.